Belong.Life Broadens Global Impact

Belong.Life, the world's largest social network for cancer patients, expands to South Africa. Photo Courtesy: 2019 SVC
Belong.Life, the world's largest social network for cancer patients, expands to South Africa. Photo Courtesy: 2019 SVC

Belong.Life, developer of the world’s largest social network for cancer patients, caregivers and healthcare providers allowing cancer patients and their support network to explore and better manage the treatment journey and improve health related quality of life (hrQoL), has partnered with The Breast Health Foundation (BHF) and The Pink Parasol Project to provide support to breast cancer patients living in South Africa.

Together, the organizations will work towards improving the quality of life for breast cancer patients by increasing access to authentic and trusted medical information, connecting individuals to medical and patient support communities and providing personalized tools to assist throughout the cancer journey.

It is estimated that 3.6%, or one in 28, South African women will develop breast cancer in their lifetime.

Mobile app
Belong.Life’s free mobile app, Belong – Beating Cancer Together, currently used by more than 200,000 cancer patients and caregivers around the world, provides customized information about treatment and recovery, clinical trial matching, emotional support forums, as well as direct access to medical experts, providers, support programs and more.

“The Breast Health Foundation and Pink Parasol project are delighted to collaborate with Belong.Life. This partnership will result in an integrated platform that shares medical and psycho-social support to all affected by Breast Cancer in South Africa,” said Louise Turner, Chief Operational Officer of the Breast Health Foundation.

Patient engagement
Belong.Life uses a hyper personalized patient engagement mobile app powered by proprietary algorithm and artificial intelligence (AI) to deliver customized content for each user. Additionally, data from the Belong.Life platform has been used to support international research projects recognized by the global oncology community, including the American Society of Clinical Oncology (ASCO) and the European Society of Medical Oncology (ESMO).

Photo 1.0: Eliran Malki, co-founder and Chief Executive Officer of Belong.Life.

“While breast cancer is common all around the world, gaps in education, lack of support and access to medical professionals persist,” said Eliran Malki, co-founder and CEO of Belong.Life.

“We are thrilled to expand our footprint to South Africa with our distinguished partners, BHF and The Pink Parasol Project, as they join our growing list of global partners including The American Cancer Society, GO2 Foundation for Lung Cancer and Colorectal Cancer Canada among others. Together we will further our shared vision to improve the quality of life for cancer patients and their families.”

End to end Engagement
Belong.Life recently launched its new Patient Engagement Platform (PEP), extending services to a wider range of therapeutic areas and providing end-to-end patient engagement solutions for global payers, pharma and hospitals.

Image 1.0: The Belong.life patient engagement platform is an end-to-end engagement solution for patients, payers, providers and pharma

The new Patient Engagement Platform (Belong PEP) leverages Belong’s machine learning (ML) and artificial intelligence (AI) expertise to provide superior engagement, user acquisition and data insights. It is available as a software as a service (SaaS) solution or a fully managed service.

“As the ‘Belong – Beating Cancer Together’ app has grown around the world, many representatives from top healthcare organizations have approached us asking for a similar patient engagement solution that could serve their audience and needs,” Malki said.

“The launch of our PEP is a natural move for us, as Belong’s vision was always to help as many patients and medical professionals as possible. Now, we are extending our solution to provide new insight to additional communities of patients, across a range of different diseases, treatment, payers, providers and recovery processes,” Malki concluded.

Reference:
ASCO 2019: The Courage and Expertese to Outsmart Cancer. The Onco’Zine Brief on PRX. | Listen to the show on PRX | Download the Program